Enhanced Ammonia Decomposition by Tuning the Support Properties of Ni/GdxCe1-xO2-δ at 600 °C.

Ammonia decomposition is a promising method to produce high-purity hydrogen. However, this process typically requires precious metals (such as Ru, Pt, etc.) as catalysts to ensure high efficiency at relatively low temperatures. In this study, we propose using several Ni/GdxCe1-xO2-δ catalysts to improve ammonia decomposition performance by adjusting the support properties. We also investigate the underlying mechanism for this enhanced performance. Our results show that Ni/Ce0.8Gd0.2O2-δ at 600 °C can achieve nearly complete ammonia decomposition, resulting in a hydrogen production rate of 2008.9 mmol.g-1.h-1 with minimal decrease over 150 h. Density functional theory calculations reveal that the recombinative desorption of nitrogen is the rate-limiting step of ammonia decomposition over Ni. Our characterizations indicate that Ni/Ce0.8Gd0.2O2-δ exhibits a high concentration of oxygen vacancies, highly dispersed Ni on the surface, and abundant strong basic sites. These properties significantly enhance the associative desorption of N and strengthen the metal support interactions, resulting in high catalytic activity and stability. We anticipate that the mechanism could be applied to designing additional catalysts with high ammonia decomposition performance at relatively low temperatures.

An Adaptive Injection Model for Pansharpening.

Pansharpening technology is used to acquire a multispectral image with high spatial resolution from a panchromatic (PAN) image and a multispectral (MS) image. The detail injection model is popular for its flexibility. However, the accuracy of the injection gain and the extracted details may greatly influence the quality of the pansharpened image. This paper proposes an adaptive injection model to solve these problems. For detail extraction, we present a Gaussian filter estimation algorithm by exploring the intrinsic character of the MS sensor and convolving the PAN image with the filter to adaptively optimize the details to be consistent with the character of the MS image. For the adaptive injection coefficient, we iteratively adjust the coefficient by balancing the spectral and spatial fidelity. By multiplying the optimized details and injection gain, the final HRMS is obtained with the injection model. The performance of the proposed model is analyzed and a large number of tests are carried out on various satellite datasets. Compared to some advanced pansharpening methods, the results prove that our method can achieve the best fusion quality both subjectively and objectively.

rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients.

The identification of single nucleotide polymorphisms (SNPs) related to aspirin resistance (AR) is of great significance for the explanation why some individuals demonstrate an incomplete response to aspirin and for optimizing the antiplatelet therapy strategy. The study was designed to investigate the possible associated genetic markers and clinical factors of AR for Chinese patients with chronic stable angina after PCI and to analyze the association between TXA2, PGI2, hs-CRP level, AR, and gene polymorphisms. Totally 207 chronic stable angina patients who received 100 mg maintenance dose daily of aspirin for more than 7 days were enrolled. The inhibition of platelets was assessed using light transmittance aggregometry. TXB2, 6-keto-PGF1α, and hs-CRP were measured by radioimmunoassay. Genotyping was performed using Taqman probe technique (rs5787 and rs5911) and gene sequencing technology (rs3842788). By using binary logistic regression analysis, the impact of clinical and genetic determinants on AR was evaluated. The prevalence of AR and aspirin semiresistance (ASR) was 3.86% and 20.76%, respectively, in Chinese chronic stable angina patients. rs5911 A/C and C/C versus A/A genotype (OR = 5.546, 95% CI = 1.812-11.404), rs3842788 A/G versus G/G genotype (OR = 8.358, 95% CI = 2.470-28.286), and blood stasis syndrome (BSS, OR = 10.220, 95% CI = 4.242-24.621) were associated with AR, but rs5787 variants were all homozygous of G/G genotype. Plasma TXB2 and hs-CRP increased significantly in AR and ASR group, while 6-keto-PGF1α showed no difference, and TXB2 level was significantly higher in carriers of the rs3842788 A/G genotype. According to our results, rs5911 and rs3842788 are proved to be specific genetic markers of AR in Chinese chronic stable angina patients for the first time, and BSS was also proved to be a remarkable determinant for AR. The AR and ASR patients were with increased plasma TXB2 and hs-CRP levels, and the TXB2 level was influenced by the variation of rs3842788 genotype.

The Effect of Xuefuzhuyu Oral Liquid on Aspirin Resistance and Its Association with rs5911, rs5787, and rs3842788 Gene Polymorphisms.

Aspirin should be continued indefinitely in patients after interventional therapy, but 10% to 40% of patients experience recurrent vascular events despite adequate aspirin therapy, a condition known as aspirin resistance (AR). Xuefuzhuyu oral liquid, derived from the classic recipe Xuefuzhuyu decoction, has been well documented to inhibit platelet aggregation and to improve hemorheology. The aims of this study were to investigate the effects of Xuefuzhuyu oral liquid on AR in patients with chronic stable angina after percutaneous coronary intervention (PCI) and the possible genetic markers related to the drug response. 43 patients diagnosed as having aspirin resistance or semi-resistance were randomly divided into control and treatment groups after screening 207 stable CHD patients. Platelet aggregation rate was determined using turbidimetry. Three single nucleotide polymorphisms in COX-1 (rs5787, rs3842788) and GP IIb (rs5911) were genotyped in whole blood samples using ABI PRISM 7900 HT Fast Real-Time instrument and ABI PRISM 3730 DNA Sequencer. The results showed that Xuefuzhuyu oral liquid could effectively improve blood stasis syndrome and AR by inhibiting ADP-induced platelet aggregation and that patients with the rs5911 genetic variant exhibited better drug response upon treatment with Xuefuzhuyu oral liquid, which suggests Xuefuzhuyu oral liquid as a new possible drug for the prevention of AR.